Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Apr 01 04:00PM ET
1.64
Dollar change
-0.07
Percentage change
-4.09
%
Index- P/E- EPS (ttm)-0.49 Insider Own7.31% Shs Outstand17.45M Perf Week-9.89%
Market Cap28.79M Forward P/E- EPS next Y-0.46 Insider Trans4.06% Shs Float16.27M Perf Month28.12%
Income-7.32M PEG- EPS next Q-0.15 Inst Own8.21% Short Float3.21% Perf Quarter-28.38%
Sales0.50M P/S57.58 EPS this Y-24.47% Inst Trans-30.95% Short Ratio3.35 Perf Half Y-45.70%
Book/sh0.56 P/B2.93 EPS next Y21.37% ROA-109.08% Short Interest0.52M Perf Year-54.82%
Cash/sh0.46 P/C3.55 EPS next 5Y6.84% ROE-108.31% 52W Range1.15 - 4.44 Perf YTD-21.90%
Dividend Est.- P/FCF- EPS past 5Y21.61% ROI-74.11% 52W High-63.06% Beta0.85
Dividend TTM- Quick Ratio29.64 Sales past 5Y40.03% Gross Margin83.24% 52W Low42.61% ATR (14)0.15
Dividend Ex-Date- Current Ratio29.64 EPS Y/Y TTM56.62% Oper. Margin-1448.67% RSI (14)51.93 Volatility6.76% 10.25%
Employees7 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin-1473.01% Recom1.00 Target Price7.50
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q-24.48% Payout- Rel Volume0.51 Prev Close1.71
Sales Surprise92.00% EPS Surprise-33.33% Sales Q/Q21.58% EarningsJan 15 Avg Volume155.95K Price1.64
SMA206.07% SMA502.11% SMA200-33.81% Trades Volume79,089 Change-4.09%
Mar-18-25 09:15AM
Feb-27-25 08:00AM
Feb-24-25 08:00AM
Feb-20-25 08:00AM
Feb-11-25 08:00AM
09:40AM Loading…
Feb-06-25 09:40AM
Feb-05-25 09:10AM
Jan-30-25 09:15AM
Jan-15-25 09:20AM
Jan-14-25 09:10AM
Dec-19-24 09:05AM
Dec-18-24 09:25AM
Dec-17-24 09:10AM
Dec-10-24 09:43AM
Dec-09-24 09:10AM
11:00AM Loading…
Nov-30-24 11:00AM
11:00AM
Nov-26-24 09:20AM
Nov-25-24 09:00AM
Nov-20-24 09:05AM
Nov-14-24 09:10AM
Nov-13-24 09:20AM
Nov-07-24 09:15AM
Oct-24-24 09:10AM
Oct-22-24 09:20AM
Oct-16-24 04:00PM
Oct-15-24 08:25AM
Oct-09-24 09:05AM
Oct-08-24 09:20AM
Oct-01-24 09:25AM
09:20AM Loading…
Sep-27-24 09:20AM
Sep-05-24 10:00AM
09:00AM
Sep-03-24 08:30AM
Aug-29-24 09:25AM
Aug-27-24 09:20AM
Aug-22-24 09:20AM
Aug-21-24 09:00AM
Aug-19-24 09:05AM
Jul-17-24 10:30AM
Jul-16-24 09:20AM
Jul-12-24 05:52PM
Jul-09-24 09:10AM
Jul-08-24 09:10AM
Jun-24-24 06:40AM
Jun-18-24 09:00AM
Jun-14-24 07:15AM
Jun-05-24 09:00AM
Jun-04-24 07:28AM
May-30-24 06:45AM
May-23-24 09:05AM
May-21-24 09:20AM
May-17-24 09:10AM
May-08-24 09:10AM
May-06-24 09:05AM
Apr-30-24 03:40PM
Apr-16-24 09:10AM
Apr-09-24 09:52PM
Apr-02-24 09:00AM
Mar-21-24 09:20AM
Mar-14-24 09:20AM
Mar-07-24 09:05AM
Mar-05-24 09:05AM
Mar-04-24 09:15AM
Mar-01-24 08:20AM
Feb-16-24 04:05PM
Feb-15-24 08:00AM
Jan-30-24 08:45AM
Jan-24-24 08:45AM
Jan-22-24 08:51AM
Jan-16-24 09:10AM
Jan-11-24 08:30AM
Jan-10-24 08:30AM
Jan-09-24 08:30AM
Jan-08-24 08:30AM
Jan-04-24 09:05AM
Dec-07-23 09:20AM
Nov-28-23 09:10AM
Nov-27-23 09:05AM
Nov-01-23 08:30AM
08:30AM
Oct-31-23 08:31AM
Oct-30-23 09:30AM
Oct-13-23 09:05AM
Oct-12-23 09:10AM
Sep-29-23 08:00AM
Sep-21-23 09:10AM
Aug-30-23 09:20AM
Aug-28-23 09:02AM
Aug-23-23 11:12AM
Aug-09-23 09:15AM
Aug-02-23 09:10AM
Jul-28-23 09:10AM
Jul-19-23 09:05AM
Jun-26-23 07:47AM
Jun-22-23 09:25AM
Jun-20-23 09:05AM
Jun-16-23 09:10AM
Jun-12-23 09:20AM
May-23-23 09:05AM
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHRISTOPHER RICHARDChief Executive OfficerDec 03 '24Buy2.4727,17267,17550,000Dec 03 02:03 PM
CHRISTOPHER RICHARDChief Executive OfficerDec 02 '24Buy2.2422,82851,21722,828Dec 03 02:03 PM
TURKEL CATHERINE C.DirectorAug 12 '24Buy3.131,6005,0083,100Aug 13 10:55 AM
Carle VanessaSecretaryJul 31 '24Sale4.002,56710,2680Aug 01 12:25 PM
Carle VanessaSecretaryMay 14 '24Option Exercise1.152,5002,8752,567May 15 05:37 PM